Acquisition Opportunity

Opportunity

• Opportunity to purchase the business and assets of an established patient engagement, recruitment and communication service provider in the healthcare and pharmaceutical sector.
• Long term contracts in place with International and UK based biopharmaceutical companies.
• c£700k future billing in current WIP to end of 2024, with contracts stretching beyond this date, subject to transfer of contracts.
• This will be a sale out of Administration.

Overview

• The Company has a strong reputation for providing exceptional levels of service worldwide, with the majority of contracts currently held with US pharmaceutical companies.
• Based in the Northwest of England, trading from leasehold premises with a workforce of 24 employees.
• Work undertaken internationally, giving the Company a worldwide presence.
• Operational office infrastructure in place with incumbent management willing to remain.
• Key Assets: Goodwill, Intellectual Property, WIP, fixtures, fittings and office equipment.

Financial Overview

• Historical Financial Performance for the Company are summarised below:

Historical P&L Performance

Expressions of Interest

• Expressions of interest are required by 5pm on Friday 28 June 2024, together with proof of funding, with completion as soon as possible thereafter.

For Further Information

Further information is available upon completion and return of a Non-Disclosure Agreement (NDA), which is available on request.

Enquires should be directed in the first instance to:

Angela O’Brien
E: aobrien@btgadvisory.com
T: 0161 837 1806